Nomura Holdings Inc. Buys New Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Nomura Holdings Inc. acquired a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 14,118 shares of the company's stock, valued at approximately $906,000.

Several other large investors also recently modified their holdings of the stock. Nuveen Asset Management LLC boosted its stake in shares of Ryan Specialty by 22.1% during the fourth quarter. Nuveen Asset Management LLC now owns 352,516 shares of the company's stock valued at $22,617,000 after purchasing an additional 63,741 shares in the last quarter. OMERS ADMINISTRATION Corp bought a new stake in shares of Ryan Specialty during the 4th quarter valued at $892,000. Millennium Management LLC increased its position in shares of Ryan Specialty by 1,111.4% during the 4th quarter. Millennium Management LLC now owns 1,174,086 shares of the company's stock valued at $75,329,000 after purchasing an additional 1,077,169 shares during the last quarter. Lighthouse Investment Partners LLC lifted its stake in shares of Ryan Specialty by 337.7% in the 4th quarter. Lighthouse Investment Partners LLC now owns 173,691 shares of the company's stock valued at $11,144,000 after purchasing an additional 134,010 shares during the period. Finally, Ensign Peak Advisors Inc increased its holdings in shares of Ryan Specialty by 160.6% in the 4th quarter. Ensign Peak Advisors Inc now owns 105,490 shares of the company's stock worth $6,768,000 after purchasing an additional 65,014 shares in the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

Ryan Specialty Stock Performance

Shares of NYSE RYAN traded down $0.03 during mid-day trading on Friday, hitting $68.69. The stock had a trading volume of 548,694 shares, compared to its average volume of 985,615. The company has a 50 day moving average of $70.10 and a two-hundred day moving average of $68.77. The firm has a market cap of $18.03 billion, a PE ratio of 99.56, a PEG ratio of 1.19 and a beta of 0.68. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a twelve month low of $52.34 and a twelve month high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, meeting analysts' consensus estimates of $0.39. The firm had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Ryan Specialty's quarterly revenue was up 25.0% compared to the same quarter last year. During the same period last year, the company posted $0.35 EPS. Research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.70%. Ryan Specialty's payout ratio is currently 141.18%.

Insider Buying and Selling

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 52.21% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. UBS Group boosted their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Morgan Stanley upped their target price on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a report on Monday, May 19th. Barclays lowered their target price on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a report on Friday, April 11th. The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and upped their target price for the stock from $74.00 to $81.00 in a report on Tuesday, May 13th. Finally, TD Cowen initiated coverage on Ryan Specialty in a report on Thursday, April 10th. They set a "buy" rating and a $89.00 target price for the company. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $75.58.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.